biotech
Worrying number of organ donations blocked by families
October 19, 2017Medical Communications biotech, drugs, organ donation, pharma, pharmaceutical
A report from the BBC has found that 505 registered organ donors had their decision blocked by relatives, over the …
Vir Biotech blasts out of the blocks, with $500m in bank
October 19, 2017Medical Communications, Sales and Marketing Vir Biotechnology, biotech, drugs, pharma, pharmaceutical
All has been quiet since former Biogen CEO, George Scangos, departed the company and then set up Vir Biotechnology in …
Gilead gets FDA nod for revolutionary blood cancer treatment
October 19, 2017Sales and Marketing CAR-T, Gilead, Yescarta, biotech, drugs, pharma, pharmaceutical
Only weeks after Gilead announced the completion of Kite, it got the news it was hoping for with the FDA’s …
Breakthrough AI able to identify 97% of breast cancer risk
October 18, 2017Research and Development MIT, biotech, breast cancer, drugs, pharma, pharmaceutical
Scientists at MIT’s Computer Science and Artificial Intelligence Laboratory have developed a machine learning AI system that is able diagnose …
New studies point to cracks forming in NHS services
October 18, 2017Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical
Two studies published separately by the BBC and the Care Quality Commission (CQC) point to growing problems across NHS services …
J&J’s third quarter: The good and the bad
October 18, 2017Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Janssen, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical
It was a mixed bag for Johnson & Johnson on its announcement of third quarter results. It could largely be …
Allergan’s patent shield – The (Native) American dream?
October 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical
In an unprecedented move, leading global pharmaceutical company Allergan appears to have handed its Orange Book-listed US patents covering …
Peanut allergies? There’s a clinical trial looking to fix that
October 17, 2017Manufacturing and Production, Research and Development Aimmune, Regeneron, Sanofi, biotech, drugs, peanuts, pharma, pharmaceutical
Aimmune Therapeutics, a biotech company developing treatments for food allergies, announced that it has entered into a clinical trial collaboration …
EMA responds to criticism of its cancer drug approvals
October 17, 2017Manufacturing and Production, Medical Communications Cancer, EMA, biotech, drugs, oncology, pharma, pharmaceutical
The EMA received a broadside just less than two week ago from a group of researchers that had studied data …
Trump suggests he will declare opioid national emergency next week
October 17, 2017Manufacturing and Production, Sales and Marketing President trump, Trump, biotech, drugs, pharma, pharmaceutical
Back in August, President Trump had suggested that the opioid epidemic that is ravaging the US would be declared a …
Simplify your regulatory processes
October 16, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, veeva
It’s always crunch time for regulatory operations. Whether you’re managing plans and documents for an upcoming IND or producing routine product variations, …
Trials reveal two strong vaccine candidates for Ebola
October 16, 2017Research and Development, Sales and Marketing Ebola, biotech, drugs, pharma, pharmaceutical
Two clinical-stage vaccine candidates for Ebola have produced stunning results, not least because an unexpected protection emerged. The two therapies …
Roche launches Warp Drive antibiotic collaboration for $387m
October 16, 2017Sales and Marketing Antibiotics, Roche, biotech, drugs, pharma, pharmaceutical
Roche had tentatively begun to re-enter the antibiotic space, but it has now signalled its growing intention to move in …
Breakthrough study could revolutionise MS treatment
October 13, 2017Medical Communications, Research and Development biotech, drugs, multiple sclerosis, pharma, pharmaceutical
The results of a study from the University of California, San Francisco will be welcomed with a certain excitement from …
Free Webinar: EudraVigilance changes and the impact on MAHs
October 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, eudravigilance, pharma, pharmaceutical, primevigilance
Following on from the popularity of our previous free webinar sessions, Pharmafocus is once again partnering with PrimeVigilance to bring you an overview of the EudraVigilance changes and their impact on MAHs.
